Designed for clinicians of all disciplines, this course provides an evidence-based overview of effective psychopharmacological interventions for key disorders and symptoms experienced by adult cancer patients, with the goal of supporting quality of life across the cancer care continuum.

This conference offers comprehensive training in clinical cancer genetics for both genetics and non-genetics healthcare professionals. The program provides CME credits, Maintenance of Certification, and continuing education units (CEUs).

This course provides a comprehensive, multimodality update on radiologic interpretation across the body in patients with cancer, including pediatric and special population considerations and innovative imaging applications in interventional oncology. Available live virtually or on demand.

This interprofessional two-day course aims to educate professional stakeholders caring for older patients on the complexities of cognitive decline as well as communicating with patients (and their families) in these challenging medical encounters.

This symposium brings together leading experts to highlight recent advances and address challenges in cardiovascular care for patients with cancer. Through lectures, case reviews, and interactive discussions, the program will explore emerging innovations shaping the future of cardio-oncology.

This course provides a comprehensive, multimodality update on radiologic interpretation across the body in patients with cancer, including pediatric and special population considerations and innovative imaging applications in interventional oncology. Participate live virtually or view on demand.

The Cancer Bioethics Consortium, in collaboration with the MSK Ethics Committee, presents this complimentary virtual conference designed for professionals across the oncology spectrum to explore the ethical complexities of cancer care and research.

This symposium focuses on rapid diagnosis, early detection, risk reduction, and care optimization for older adults. Participants will gain knowledge in managing multimorbidity, improving detection in high-risk populations, reducing treatment-associated risks, and leveraging emerging technologies.

This four-and-a-half–day course provides an up-to-date review of the pathology of selected subspecialty areas of neoplastic disease, including gastrointestinal (GI), thoracic, and genitourinary (GU) pathology. Participate live (in person or virtually) or view on demand.

This course provides an up-to-date review of the pathology of selected subspecialty areas of neoplastic disease, including gastrointestinal (GI), thoracic, and genitourinary (GU) pathology. Participate live (in person or virtually) or view on demand.